Analysis | Metabolite Name | Measured Value | Units | Age Group | Sex | Smoking Status | Diagnosis |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | nicotinic acid | 61 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 70 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 72 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 72 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 73 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 74 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 74 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 75 | Counts | 70-74 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 77 | Counts | 65-69 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 78 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 80 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 80 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 80 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 81 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 82 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 83 | Counts | 50-54 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 83 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 83 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 85 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 86 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 86 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 87 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 87 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 88 | Counts | 50-54 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 88 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 88 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 90 | Counts | 45-49 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 90 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 91 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 92 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 93 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 93 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 93 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 93 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 93 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 93 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 93 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 93 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 94 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 94 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 94 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 95 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 96 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 97 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 97 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 97 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 98 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 98 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 98 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 99 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 100 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 100 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 101 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 102 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 103 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 103 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 104 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 104 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 104 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 105 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 105 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 105 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 105 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 106 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 106 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 106 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 107 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 107 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 107 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 107 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 108 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 108 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 109 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 109 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 109 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 110 | Counts | 50-54 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 111 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 112 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 112 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 113 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 114 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 114 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 114 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 114 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 114 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 115 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 115 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 115 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 116 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 117 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 117 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 118 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 120 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 120 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 121 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 121 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 122 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 123 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 123 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 124 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 124 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 125 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 126 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 126 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 127 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 130 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 131 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 131 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 131 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 131 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 131 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 132 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 132 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 132 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 133 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 134 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 134 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 134 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 135 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 135 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 135 | Counts | 60-64 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 135 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 135 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 135 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 135 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 136 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 136 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 136 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 136 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 136 | Counts | 70-74 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 139 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 140 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 142 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 142 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 143 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 144 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 144 | Counts | 65-69 | Female | Former | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 146 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 147 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 147 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 148 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 149 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 150 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 151 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 151 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 154 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 155 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 157 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 158 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 158 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 158 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 159 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 159 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 160 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 160 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 160 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 161 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 161 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 162 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 163 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 163 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 163 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 164 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 165 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 167 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 168 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 169 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 169 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 170 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 171 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 173 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 176 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 178 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 182 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 184 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 189 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 190 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 192 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 193 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 193 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 196 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 197 | Counts | 55-59 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 201 | Counts | 60-64 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 201 | Counts | 70-74 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 203 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 207 | Counts | 65-69 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | nicotinic acid | 209 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 213 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 214 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 216 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 217 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 217 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 218 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | nicotinic acid | 222 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | nicotinic acid | 224 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 233 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 241 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | nicotinic acid | 241 | Counts | 65-69 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 243 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | nicotinic acid | 244 | Counts | 50-54 | Male | Current | Adenocarcinoma |
Return to search page